Cited by 45Alzheimer's disease research and treatmentsDown syndrome and intellectual disability researchDementia and Cognitive Impairment Research

Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome

Motonaga, Kozo, Itoh, Masayuki, Becker, Laurence E., Goto, Yu-ichi, Takashima, Sachio·2002·Neuroscience Letters

Abstract

The gene encoding the beta-site amyloid precursor protein cleaving enzyme 2 (BACE2) has been determined to be located on the long arm of chromosome 21 at 21q22.3. BACE2 cleaves the amyloid precursor protein at the beta-secretase site and is thought to contribute to amyloid beta protein production. In the present study, changes in the expression of BACE2 were investigated immunohistochemically in the frontal cortex of patients with Down syndrome (DS). The immunoreactivity for BACE2 was detected in neurofibrillary tangle-bearing neurons from the elderly DS brains with Alzheimer-type neuropathology, but were not detected in those of DS brains without Alzheimer-type neuropathology or of control brains of any age. This suggests the possibility that the elevated expression of BACE2 is involved in the Alzheimer-type neuropathology of DS.

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(02)00287-2

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Motonaga, K., Itoh, M., Becker, L. E., Goto, Y.-I., & Takashima, S.
Affiliations
  • National Center of Neurology and Psychiatry (JP)
  • Hospital for Sick Children (CA)
Corresponding author
Motonaga, Kozo
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2002-06
Volume
326
Issue
1
Pages
64-66
ISSN
0304-3940 (ISSN-L)
OpenAlex
W2014284997
Cited by
45
References
0
Citations by year
2022: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 1 · 2014: 1 · 2012: 1
FWCI
2.60
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
BACE2, Down syndrome, amyloid-beta, neurofibrillary tangles, frontal cortex, gene expression, chromosome 21, beta-secretase
MeSH terms
Adolescent, Adult, Age Factors, Alzheimer Disease, Autopsy, Child, Child, Preschool, Down Syndrome, Frontal Lobe, Humans, Immunohistochemistry, Infant, Middle Aged, Endopeptidases, Immunoblotting, Up-Regulation, Gene Expression Regulation, Enzymologic, Aspartic Acid Endopeptidases, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review